From Human Oncology
Researchers in the DHO pursue basic, translational and clinical research involving ionizing and non-ionizing radiation in the diagnosis, early-detection, molecular imaging, staging and treatment of cancer. This is a truly multidisciplinary endeavor creating and exploiting synergies between multiple research fields: basic molecular and cancer biology, medical imaging, radiation physics, bioinformatics, biostatistics, pre-clinical and translational research, clinical trials and outcome studies. We continue to expand a fertile research environment within the DHO, the UWCCC, the UW and networking with other research groups nationally and internationally as well as through active participation and leadership in clinical cooperative research groups (RTOG, ECOG, COG, NABTC).
DHO faculty play key roles in the multi-disciplinary Disease-oriented Working Groups (DOWGs) within the UWCCC including head and neck, neuro-oncology, pediatric, breast, genitourinary, gastrointestinal, and lung cancer. This has led to several of these groups conducting Phase I and II studies of new radiation techniques and/or fractionation schedules and of new drug-radiation combinations. Some of these strategies have been carried on to Phase II and III trials.
DHO research is funded through a multitude of sources, including several RO1s, through the NCI comprehensive cancer center grant as well as substantial support from UW and from industry.
Research interests of individual DHO faculty can be found on individual faculty pages.